Circle Pharma, Inc., a clinical-stage biopharmaceutical company, has partnered with Eli Lilly and Company to use Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform designed to accelerate the development of new medicines by providing biotech companies access to powerful drug discovery models that have been trained on Lilly’s proprietary research data. Circle Pharma will leverage Lilly TuneLab to further strengthen its AI/ML capabilities and proprietary MXMO platfor...